Robert Gunther > WilmerHale > Boston, United States > Lawyer Profile
WilmerHale Offices
60 STATE STREET
BOSTON, MA 02109
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Robert Gunther
Work Department
Intellectual Property Litigation; Litigation; Trials; Life Sciences; Big Data
Position
Partner
Career
Robert Gunther has over 35 years of experience as a trial lawyer representing life sciences, pharmaceutical and technology clients in intellectual property and technology litigation at both the trial and appellate levels. Mr. Gunther is a Fellow of the American College of Trial Lawyers, and he has consistently been selected by Chambers USA, Managing IP magazine, LMG Life Sciences and IAM as a leading lawyer in the area of patent litigation.
Mr. Gunther has successfully tried patent, trademark, trade secret, license disputes and other intellectual property cases before numerous federal district courts, state courts and arbitration tribunals. He has also argued appeals before the US Court of Appeals for the Federal Circuit, litigated patent disputes before the US International Trade Commission and litigated inter partes review proceedings before the Patent Trial and Appeal Board of the US Patent and Trademark Office.
Mr. Gunther has handled cases involving an array of technologies, including biotechnology, pharmaceuticals, medical devices, financial methodologies, petrochemical processes, computer hardware and software, telecommunications and networking, video game and graphic display hardware and software, optical discs and consumer products, among others. His intellectual property clients have included Abbott Laboratories, Affymetrix, Ariosa, Cephalon, Chugai Pharmaceutical, Eastman Kodak Company, Genentech, Memorial Sloan Kettering Cancer Center, Mentor Graphics, Nintendo, Playtex Products, QinetiQ, Reckitt Benckiser, Roche Diabetes Care, Roche Molecular Systems, Sumitomo Electric, Swatch / Omega and WebMD.
Most recently, during May / June 2022, Mr. Gunther led a trial team that successfully defended Reckitt Benckiser against claims of fraud and trade secret misappropriation relating to an over-the-counter pharmaceutical product in federal court in Newark, New Jersey. Following a four week trial, the jury unanimously ruled in favor of Reckitt on all issues.
From 2018 to 2021, Mr. Gunther was a member of WilmerHale’s Management Committee.
Education
St. John’s University School of Law , J.D. (1984)
St. John’s University , B.A. (1981)
Lawyer Rankings
United States > Healthcare > Life sciences
WilmerHale’s primarily Boston-based team advises a range of clients, including diagnostic and medical device corporates, universities and research institutions, and investment banks. Practice co-chair Stuart Falber advises a range of public life science companies on capital markets related matters, while fellow co-chair Lisa Pirozzolo acts in Hatch-Waxman cases and licensing disputes, often appearing before the ITC and the PTAB. Based in New York, David Bassett has an IP litigation focused practice, and often contends with biotech and pharmaceutical patent disputes alongside Robert Gunther, who also handles trade secret cases before arbitration tribunals. Sarah Hogan focuses on the life sciences and digital health industries, and has a great deal of experience in the negotiation of IP licenses and strategic collaborations.
Lawyer Rankings
Top Tier Firm Rankings
- Finance > Financial services regulation
- Antitrust > Cartel
- International Trade > CFIUS
- Antitrust > Civil litigation/class actions: defense
- Industry focus > Education
- Industry focus > Native American law
- Intellectual property > Patents: litigation (full coverage)
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > General commercial disputes
- M&A/corporate and commercial > M&A: middle-market ($500m-999m)
- Media, technology and telecoms > Outsourcing
- Dispute resolution > Securities litigation: defense
- Government > State attorneys general
- Media, technology and telecoms > Technology transactions
- M&A/corporate and commercial > Venture capital and emerging companies
- Finance > Capital markets: equity offerings
- M&A/corporate and commercial > Corporate governance
- Government > Government contracts
- Dispute resolution > International arbitration
- Healthcare > Life sciences
- International Trade > Trade remedies and trade policy
- Finance > Capital markets: debt offerings
- International Trade > Customs, export controls and economic sanctions
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: regulatory
- Dispute resolution > Financial services litigation
- Finance > Fintech
- Government > Government relations
- Antitrust > Merger control
- Tax > US taxes: non-contentious
- Finance > Commercial lending
- Dispute resolution > Leading trial lawyers
- Real estate > Real estate
- Finance > Restructuring (including bankruptcy): corporate
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Environment > Environment: litigation